Safety of nalmefene for the treatment of alcohol use disorder: an update Autor: López-Pelayo H, Zuluaga P, Caballeria E, Van den Brink W, Mann K, Gual A. Revista: Expert Opin Drug Saf. 2020 Jan;19(1):9-17 Fuente: Expert Opinion on Drug Safety Volver a Publicaciones ← Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment Acute Effects of 2C-E in Humans: An Observational Study →
